pyrithione has been researched along with 2,3-dihydroxybenzoic acid in 2 studies
*2,3-dihydroxybenzoic acid: RN given refers to parent cpd [MeSH]
*2,3-dihydroxybenzoic acid: RN given refers to parent cpd [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT | 1 |
| Blatt, J; Kontoghiorghes, GJ; Taylor, SR | 1 |
2 other study(ies) available for pyrithione and 2,3-dihydroxybenzoic acid
| Article | Year |
|---|---|
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc | 2011 |
Comparison of activity of deferoxamine with that of oral iron chelators against human neuroblastoma cell lines.
Topics: Administration, Oral; Cell Cycle; Cell Survival; Deferiprone; Deferoxamine; Humans; Hydroxybenzoates; Neuroblastoma; Pyridines; Pyridones; Thiones; Tumor Cells, Cultured | 1989 |